Life Science Angels
Life Science Angels is a California-based, not-for-profit angel investment organization founded in 2005 that deploys member capital exclusively into early-stage US life science companies across biotech, medical devices, and digital health, serving 130-150 accredited investor members and having invested $60M+ into 100+ companies.
- Company typePrivate
- Founded2005
- HeadquartersSunnyvale, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Life Science Angels does
Life Science Angels (LSA) is a California-based, not-for-profit angel investment organization incorporated in 2005 as a Mutual Benefit Corporation by Allan May (Chairman of the Board) and Casey McGlynn (retired Chairman of the Life Sciences Group at Wilson Sonsini Goodrich & Rosati). LSA invests exclusively in early-stage life science companies incorporated as US C-Corporations, organized across three portfolio verticals: Bio/Genomics (therapeutics, drug discovery, genomics tools), Medical Devices, and Digital Health. Since founding, LSA has deployed over $60 million across 100+ portfolio companies at initial check sizes of $100K-$1.1M, typically syndicated into rounds of $3M+, with member minimums of $5K per deal and a 6-member participation threshold for first-time investments.
LSA is not a technology product company; its core offering is a structured investment service built on a 4-stage process (Pre-Screening, Bi-weekly Screening Meetings, Due Diligence, Investment) executed by 130-150 US-Accredited Angel Investor members, 18 Investment Fellows, and 9 sponsor organizations. Members pool capital through single-purpose LLCs so LSA writes one check and appears as a single investor on portfolio company cap tables, preferring board or observer representation. Supporting services include the LSA Investment Fellows Program (a 6-12 month fellowship for graduate students, postdocs, and early-career professionals) and the @LSA Series of collaborations with academic and corporate accelerators.
LSA's business model is membership-fee subscription recurring revenue: Individual $2,330/year, Couples/Families $3,365/year, and Affiliate (Family Office/VC) $5,175/year, supplemented by sponsor organization support. LSA takes no carry, no management fees, and charges portfolio companies nothing. Distribution is community-led through member referrals, accelerator partnerships (SkyDeck, MedTech Innovator, IndieBio), and direct application via the Dealum platform. Notable exits include Amplyx (sold to Pfizer), Advanced Cardiac Therapeutics (acquired by Medtronic), Nanostim leadless pacemaker (acquired by St. Jude Medical/Abbott), and Axsome (IPO). LSA was recognized as the #1 Angel Group by CB Insights in 2014.
Life Science Angels firmographics
Firmographics- Name
- Life Science Angels
- Legal name
- Life Science Angels, Inc.
- Website
- https://lifescienceangels.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Life Science Angels is a California-based, not-for-profit angel investment organization founded in 2005 that deploys member capital exclusively into early-stage US life science companies across biotech, medical devices, and digital health, serving 130-150 accredited investor members and having invested $60M+ into 100+ companies.
- Ownership category
- akta.pro rank
Life Science Angels industry classification
Industry- Product category
- Angel Investment Services (Life Sciences)
- NAICS
- Other Financial Vehicles (525990)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Micro-VC & Angel Funds (FSANAAAI)
Keywords
Where Life Science Angels is headquartered
LocationHeadquarters
- HQ city
- Sunnyvale
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Life Science Angels business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Membership Fees: LSA charges annual membership fees for individual, couples/families, and affiliate memberships. They are a California Mutual Benefit Corporation (not-for-profit) and take no carry or management fees on investments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Individual Membership for single accredited angel investors |
| Subscription | Annual | Couples/Families Membership for two family members |
| Subscription | Annual | Affiliate Membership for family offices and venture capital entities |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Life Science Angels product offering
Product offeringCore offering
Life Science Angels is an angel investment organization that pools capital from 130-150 U.S.-accredited investor members to fund early-stage life science companies exclusively across Bio/Genomics, Medical Devices, and Digital Health. LSA runs a four-stage investment process (Pre-Screening, Bi-weekly Screening Meetings, Due Diligence, Investment), writes one check per company appearing as a single investor on cap tables, and provides active support through board/observer roles and follow-on participation. Membership is annual and tiered (Individual $2,330, Couples/Families $3,365, Affiliate $5,175); no carry, management fees, or company fees are charged.
Product overview
Life Science Angels (LSA) is a California-based angel investment organization, not a product company. LSA's core offering is investment services connecting early-stage life science companies with capital through their network of 130-150 accredited investor members and 18 investment fellows. They invest exclusively in life sciences across three verticals: Bio/Genomics (therapeutics, drug discovery, genomics tools), Medical Devices, and Digital Health. LSA has invested in 100+ companies deploying over $60 million since 2005. The Investment Fellows Program provides educational experience in life science investing. Portfolio companies include notable exits such as Amplyx (sold to Pfizer), Advanced Cardiac Therapeutics (acquired by Medtronic), and Axsome (IPO).
Differentiator
Problem solved
Functional benefit
Products and services
- LSA Individual Membership Annual membership tier priced at $2,330 for single accredited angel investors. Includes all membership benefits, access to vetted life science deal flow, due diligence participation, and the ability to invest alongside other members through the LSA LLC.
- LSA Couples/Families Membership Annual membership tier priced at $3,365 covering two family members or partners (one additional family member or significant other included). Provides the same deal flow, due diligence, and investment benefits as individual membership.
- LSA Affiliate Membership Annual membership tier priced at $5,175 designed for individual and/or investing entities such as Family Offices and Venture Capital firms. Provides access to LSA-sourced investment opportunities, executed outside the LSA LLC structure.
- LSA Angel Investment Program (Early-Stage Life Science Companies) Core angel investment program providing deal screening, due diligence, and pooled funding (typically $100K to $1.1M per company, with syndicated rounds of $3M or more) to early-stage U.S. C-Corp life science startups in Bio/Genomics, Medical Devices, and Digital Health. LSA writes one check per investment and appears as a single investor on portfolio company cap tables, with active board/observer support.
- LSA Investment Fellows Program A six-month to one-year fellowship program offering hands-on training in life science innovation, entrepreneurship, and investing. Fellows assist in deal screening and due diligence and work within the Bio/Genomics Committee or Device/Digital Committee. Designed for graduate students, postdocs, medical trainees, and early-career professionals.
Quantifiable outcome
- 100+ companies invested since 2005
- +2 more outcomes
Companies that use Life Science Angels
Customer profileNamed customers9 records
Segments2 records
Ideal customer profiles2 records
Life Science Angels technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Life Science Angels partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- SkyDeckcoreUC Berkeley's accelerator program. Recognized partner for referring companies to LSA for investment consideration.
- MedTech InnovatorcoreLeading accelerator for medical technology companies. Recognized partner for referring companies to LSA for investment consideration.
- IndieBiocoreSOSV's life sciences accelerator. Recognized partner for referring companies to LSA for investment consideration.
Scale indicators5 records
Recent moves5 records
Expansion highlights4 records
Life Science Angels competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Life Science Angels financial estimates
Financial estimateRevenue estimate
Valuation estimate
Life Science Angels leadership team
Management profileNumber of profiles
Profiles14 records
Life Science Angels funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Life Science Angels M&A and investment
M&A and investmentM&A
Investments96 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Life Science Angels
What does Life Science Angels do?
Life Science Angels is an angel investment organization that pools capital from 130-150 U.S.-accredited investor members to fund early-stage life science companies exclusively across Bio/Genomics, Medical Devices, and Digital Health. LSA runs a four-stage investment process (Pre-Screening, Bi-weekly Screening Meetings, Due Diligence, Investment), writes one check per company appearing as a single investor on cap tables, and provides active support through board/observer roles and follow-on participation. Membership is annual and tiered (Individual $2,330, Couples/Families $3,365, Affiliate $5,175); no carry, management fees, or company fees are charged.
Is Life Science Angels a public or private company?
Life Science Angels is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Life Science Angels founded?
Life Science Angels was founded in 2005. It employs 101 to 250 people.
Where is Life Science Angels based?
Life Science Angels is headquartered in Sunnyvale, United States, in the North America region.
How does Life Science Angels make money?
One revenue line is on record: membership Fees.
Does Life Science Angels have an API?
No public API is recorded for Life Science Angels.
What industry is Life Science Angels in?
Life Science Angels's product category is Angel Investment Services (Life Sciences). Its primary akta.pro industry code is FSANAAAI, Micro-VC & Angel Funds. Its NAICS code is 525990 and its SIC code is 6282.